{"id":36932,"date":"2026-02-25T08:13:10","date_gmt":"2026-02-25T16:13:10","guid":{"rendered":"https:\/\/getheally.com\/patients\/news\/how-ozempic-works-and-why-it-might-affect-libido-copy"},"modified":"2026-02-26T07:41:43","modified_gmt":"2026-02-26T15:41:43","slug":"ozempic-thyroid-cancer-research","status":"publish","type":"post","link":"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research","title":{"rendered":"Ozempic Thyroid Cancer: What the Research Actually Says"},"content":{"rendered":"<p data-start=\"627\" data-end=\"1135\">Understanding the relationship between Ozempic thyroid cancer concerns and actual scientific evidence helps individuals make informed decisions about <a href=\"https:\/\/getheally.com\/patients\/weight-loss-prescription\">GLP-1 medications<\/a>. Questions about whether Ozempic causes thyroid cancer require careful examination of <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37531876\/\">research findings<\/a> to separate evidence from speculation.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">This guide explores what studies actually show about Ozempic medullary thyroid cancer risk, GLP-1 thyroid cancer connections, and Ozempic safety thyroid considerations to support informed discussions with healthcare providers.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Important Note: Current evidence does not demonstrate that Ozempic causes thyroid cancer in humans. This content examines the scientific basis for warnings and who may need additional caution.<\/p>\n<h2 id=\"why-people-worry-about-ozempic-and-thyroid-cancer\" class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">Why People Worry About Ozempic and Thyroid Cancer<\/h2>\n<h3 id=\"origins-of-concern\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Origins of Concern<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The Ozempic thyroid warning stems from <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37531876\/\">preclinical animal studies<\/a> conducted before the medication&#8217;s approval. During drug development, rodent studies showed thyroid C-cell tumors in rats and mice treated with semaglutide and other <a href=\"https:\/\/getheally.com\/patients\/news\/semaglutide-vs-other-glp-1\">GLP-1 receptor agonists<\/a>. These findings required inclusion of a boxed warning in the medication&#8217;s prescribing information.<\/p>\n<h3 id=\"media-and-social-media-amplification\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Media and Social Media Amplification<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Discussions about Ozempic thyroid cancer risk have spread rapidly across social media platforms, often without an appropriate scientific context. Headlines emphasizing cancer warnings can create alarm without explaining the limitations of animal studies or the lack of confirmed human cases.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Many individuals encounter alarming posts or articles about thyroid cancer risk without understanding that:<\/p>\n<ul class=\"[li_&amp;]:mb-0 [li_&amp;]:mt-1 [li_&amp;]:gap-1 [&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\">\n<li class=\"whitespace-normal break-words pl-2\">Animal study findings don&#8217;t always translate to humans<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Doses used in animal studies far exceed human therapeutic doses<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Clinical trials and post-marketing surveillance have not confirmed increased thyroid cancer risk in humans<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Certain individuals at higher baseline risk require specific precautions<\/li>\n<\/ul>\n<h3 id=\"setting-the-record-straight\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Setting the Record Straight<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">While concerns are understandable given the boxed warning, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10490004\/\">examining the actual evidence<\/a> also provides important context. The warning reflects regulatory caution based on animal data and theoretical risk rather than confirmed human cases. This doesn&#8217;t mean the medication is risk-free, but it clarifies that current human evidence doesn&#8217;t support widespread cancer concerns for most users.<\/p>\n<h2 id=\"what-research-in-animals-shows\" class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">What Research in Animals Shows<\/h2>\n<h3 id=\"preclinical-study-findings\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Preclinical Study Findings<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Animal studies testing semaglutide and other GLP-1 medications documented thyroid C-cell tumors (medullary thyroid carcinoma) in rodents. These tumors developed in rats and mice exposed to GLP-1 receptor agonists during lifetime exposure studies required for drug development.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The mechanism appears related to GLP-1 receptor stimulation in thyroid C-cells, which produce calcitonin. Chronic stimulation of these receptors may lead to C-cell hyperplasia (increased cell growth) and eventually tumor formation in rodents.<\/p>\n<h3 id=\"critical-limitations\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Critical Limitations<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Dose differences:<\/strong> Animal studies used doses significantly higher than human therapeutic doses, often many times the maximum recommended human dose. This helps identify potential risks but doesn&#8217;t directly predict human outcomes.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Species differences:<\/strong> Rodents have different thyroid physiology compared to humans. Rats and mice have a higher density of GLP-1 receptors in thyroid C-cells than humans, potentially making them more susceptible to C-cell effects.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Study duration:<\/strong> Lifetime exposure studies in rodents span their entire lifespan, providing chronic exposure scenarios that may not reflect typical human use patterns.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Extrapolation challenges:<\/strong> Many compounds cause tumors in rodents at high doses that don&#8217;t cause cancer in humans. The relevance of rodent thyroid findings to human risk remains uncertain.<\/p>\n<h3 id=\"regulatory-response\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Regulatory Response<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Based on these animal findings, regulatory agencies required a boxed warning about the potential thyroid C-cell tumor risk. This represents a precautionary approach acknowledging animal data while recognizing that human relevance remains unclear.<\/p>\n<h2 id=\"what-human-studies-and-clinical-trials-show\" class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">What Human Studies and Clinical Trials Show<\/h2>\n<h3 id=\"clinical-trial-evidence\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Clinical Trial Evidence<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Extensive <a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1607141\">clinical trials<\/a> involving tens of thousands of participants have been conducted with semaglutide and other <a href=\"https:\/\/getheally.com\/patients\/tirzepatide\">GLP-1 medications<\/a>. These trials included monitoring for thyroid adverse events and cancer incidence.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Key findings from trials:<\/strong><\/p>\n<ul class=\"[li_&amp;]:mb-0 [li_&amp;]:mt-1 [li_&amp;]:gap-1 [&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\">\n<li class=\"whitespace-normal break-words pl-2\">No confirmed cases of medullary thyroid carcinoma (MTC) in semaglutide trials<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Thyroid cancer incidence in trial participants was similar to the expected background rates<\/li>\n<li class=\"whitespace-normal break-words pl-2\">No statistical signal suggesting increased thyroid cancer risk in treated populations<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Long-term extension studies continue to monitor participants<\/li>\n<\/ul>\n<h3 id=\"post-marketing-surveillance\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Post-Marketing Surveillance<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Since approval, regulatory agencies and manufacturers monitor real-world use through post-marketing surveillance systems. These systems track adverse events reported by healthcare providers and patients.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Surveillance findings:<\/strong><\/p>\n<ul class=\"[li_&amp;]:mb-0 [li_&amp;]:mt-1 [li_&amp;]:gap-1 [&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\">\n<li class=\"whitespace-normal break-words pl-2\">Millions of patients have used GLP-1 medications worldwide<\/li>\n<li class=\"whitespace-normal break-words pl-2\">No confirmed pattern of increased thyroid cancer cases above baseline expectations<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Continued monitoring for potential signals<\/li>\n<\/ul>\n<h3 id=\"population-studies\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Population Studies<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12303005\/\">Large-scale epidemiological studies<\/a> examining GLP-1 medication users in real-world populations have not demonstrated increased thyroid cancer incidence compared to similar populations not using these medications.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Important context:<\/strong> Absence of evidence is not definitive evidence of absence, particularly for rare outcomes requiring very large populations and long follow-up periods. However, current human data provides reassurance that if risk exists, it appears to be very low for most individuals.<\/p>\n<h2 id=\"understanding-medullary-thyroid-cancer-mtc\" class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">Understanding Medullary Thyroid Cancer (MTC)<\/h2>\n<h3 id=\"what-mtc-is\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">What MTC Is<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Medullary thyroid cancer represents a rare form of thyroid cancer originating from thyroid C-cells that produce calcitonin. MTC accounts for only 1-2% of all thyroid cancers, making it uncommon even among thyroid malignancies.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Characteristics:<\/strong><\/p>\n<ul class=\"[li_&amp;]:mb-0 [li_&amp;]:mt-1 [li_&amp;]:gap-1 [&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\">\n<li class=\"whitespace-normal break-words pl-2\">Often produces elevated calcitonin levels detectable in blood tests<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Can occur sporadically or as part of hereditary syndromes<\/li>\n<li class=\"whitespace-normal break-words pl-2\">It is generally more aggressive than common thyroid cancers (papillary or follicular)<\/li>\n<li class=\"whitespace-normal break-words pl-2\">May occur with other endocrine tumors in genetic syndromes<\/li>\n<\/ul>\n<h3 id=\"genetic-risk-factors\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Genetic Risk Factors<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Approximately 25% of MTC cases are hereditary, associated with mutations in the RET gene. These hereditary cases occur in conditions called Multiple Endocrine Neoplasia type 2 (MEN 2):<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>MEN 2A:<\/strong> Includes medullary thyroid cancer, pheochromocytoma (adrenal tumors), and parathyroid disease<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>MEN 2B:<\/strong> Includes medullary thyroid cancer, pheochromocytoma, and distinctive physical features<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Familial MTC:<\/strong> Medullary thyroid cancer without other endocrine tumors<\/p>\n<h3 id=\"why-mtc-matters-for-glp-1-medications\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Why MTC Matters for GLP-1 Medications<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The Ozempic medullary thyroid cancer connection relates to the <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20203154\/\">animal study<\/a> findings showing C-cell tumors. Since medullary thyroid cancer originates from C-cells, and GLP-1 receptors are present on these cells, concerns exist about stimulation potentially affecting cancer risk.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Critical distinction:<\/strong> Having a genetic predisposition to MTC represents a clear contraindication to GLP-1 medications. The warning primarily protects this specific high-risk population rather than suggesting general population risk.<\/p>\n<h2 id=\"fda-guidance-and-labeling\" class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">FDA Guidance and Labeling<\/h2>\n<h3 id=\"boxed-warning\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Boxed Warning<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The FDA-mandated boxed warning (black box warning) for semaglutide and other GLP-1 medications states that thyroid C-cell tumors occurred in animal studies, while it&#8217;s unknown whether this occurs in humans.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Warning language emphasizes:<\/strong><\/p>\n<ul class=\"[li_&amp;]:mb-0 [li_&amp;]:mt-1 [li_&amp;]:gap-1 [&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\">\n<li class=\"whitespace-normal break-words pl-2\">Contraindication in patients with a personal or family history of MTC<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Contraindication in patients with MEN 2<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Unknown human relevance of animal findings<\/li>\n<\/ul>\n<h3 id=\"contraindications\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Contraindications<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Ozempic safety thyroid guidance specifically contraindicates use in:<\/p>\n<ul class=\"[li_&amp;]:mb-0 [li_&amp;]:mt-1 [li_&amp;]:gap-1 [&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\">\n<li class=\"whitespace-normal break-words pl-2\">Patients with a personal history of medullary thyroid carcinoma<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Patients with a family history of medullary thyroid carcinoma<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Patients with Multiple Endocrine Neoplasia syndrome type 2<\/li>\n<\/ul>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Healthcare providers should screen for these conditions before prescribing semaglutide.<\/p>\n<h3 id=\"monitoring-recommendations\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Monitoring Recommendations<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">FDA guidance does not recommend routine calcitonin monitoring in patients using GLP-1 medications without specific risk factors. Routine screening in general populations has not been shown to be beneficial and may lead to false positive results and unnecessary interventions.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Healthcare provider responsibilities:<\/strong><\/p>\n<ul class=\"[li_&amp;]:mb-0 [li_&amp;]:mt-1 [li_&amp;]:gap-1 [&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\">\n<li class=\"whitespace-normal break-words pl-2\">Screen for contraindications before prescribing<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Educate patients about thyroid cancer symptoms<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Respond appropriately to concerning symptoms if they develop<\/li>\n<\/ul>\n<h2 id=\"who-should-discuss-ozempic-thyroid-cancer-with-their-healthcare-provider\" class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">Who Should Discuss Ozempic Thyroid Cancer with Their Healthcare Provider<\/h2>\n<h3 id=\"high-priority-discussions\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">High-Priority Discussions<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Certain individuals require specific discussions about semaglutide thyroid cancer risk before starting treatment:<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Personal or family history of MTC:<\/strong> Any history of medullary thyroid cancer in yourself or close family members represents an absolute contraindication. Discuss alternative treatment options.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Known or suspected MEN 2:<\/strong> Genetic testing may be appropriate if family history suggests this syndrome. Confirmed or suspected MEN 2 contraindicates GLP-1 medications.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Unexplained thyroid nodules:<\/strong> If you have thyroid nodules that haven&#8217;t been evaluated, discuss an appropriate workup before starting GLP-1 therapy.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Prior thyroid conditions:<\/strong> While most thyroid conditions (like hypothyroidism or common thyroid cancers) don&#8217;t contraindicate GLP-1 use, discuss your specific situation with your provider.<\/p>\n<h3 id=\"questions-to-ask\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Questions to Ask<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Before starting treatment:<\/strong><\/p>\n<ul class=\"[li_&amp;]:mb-0 [li_&amp;]:mt-1 [li_&amp;]:gap-1 [&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\">\n<li class=\"whitespace-normal break-words pl-2\">&#8220;Given my medical and family history, do I have any contraindications to this medication?&#8221;<\/li>\n<li class=\"whitespace-normal break-words pl-2\">&#8220;What symptoms should I watch for related to thyroid concerns?&#8221;<\/li>\n<li class=\"whitespace-normal break-words pl-2\">&#8220;Do I need any baseline thyroid testing?&#8221;<\/li>\n<\/ul>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>During treatment:<\/strong><\/p>\n<ul class=\"[li_&amp;]:mb-0 [li_&amp;]:mt-1 [li_&amp;]:gap-1 [&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\">\n<li class=\"whitespace-normal break-words pl-2\">&#8220;Are there any new symptoms I should report immediately?&#8221;<\/li>\n<li class=\"whitespace-normal break-words pl-2\">&#8220;When should I have follow-up appointments?&#8221;<\/li>\n<\/ul>\n<h3 id=\"when-to-contact-providers\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">When to Contact Providers<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Contact healthcare providers if you develop:<\/p>\n<ul class=\"[li_&amp;]:mb-0 [li_&amp;]:mt-1 [li_&amp;]:gap-1 [&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\">\n<li class=\"whitespace-normal break-words pl-2\">Lump or swelling in the neck<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Hoarseness that persists<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Difficulty swallowing<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Shortness of breath<\/li>\n<\/ul>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">These symptoms warrant evaluation regardless of medication use, but should be reported promptly when using GLP-1 medications.<\/p>\n<h2 id=\"common-myths-and-misconceptions\" class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">Common Myths and Misconceptions<\/h2>\n<h3 id=\"myth-ozempic-will-give-you-thyroid-cancer\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Myth: &#8220;Ozempic Will Give You Thyroid Cancer&#8221;<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Reality:<\/strong> Current human evidence does not demonstrate that Ozempic causes thyroid cancer in general populations. Animal studies showed tumors at high doses in rodents, but extensive human clinical trials and real-world use have not confirmed increased cancer incidence. The warning reflects precautionary labeling based on animal data, not confirmed human risk.<\/p>\n<h3 id=\"myth-if-you-take-it-long-enough-cancer-is-guaranteed\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Myth: &#8220;If You Take It Long Enough, Cancer Is Guaranteed&#8221;<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Reality:<\/strong> Ozempic long-term risks regarding thyroid cancer remain theoretical rather than demonstrated. Millions of patients have used GLP-1 medications for years without confirmed thyroid cancer patterns emerging. Long-term studies continue, but current evidence doesn&#8217;t support inevitable cancer development.<\/p>\n<h3 id=\"myth-the-boxed-warning-means-its-too-dangerous-to-use\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Myth: &#8220;The Boxed Warning Means It&#8217;s Too Dangerous to Use&#8221;<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Reality:<\/strong> Boxed warnings alert providers and patients to important safety information requiring attention. Many widely-used, beneficial medications carry boxed warnings for specific populations or circumstances. The Ozempic thyroid warning primarily protects individuals with a genetic predisposition rather than indicating general danger.<\/p>\n<h3 id=\"myth-all-glp-1-medications-have-the-same-thyroid-risk\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Myth: &#8220;All GLP-1 Medications Have the Same Thyroid Risk&#8221;<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Reality:<\/strong> While GLP-1 thyroid cancer warnings apply to the medication class based on similar animal findings, individual medications may have slightly different profiles. However, all share similar warnings due to class effects observed in animal studies.<\/p>\n<h3 id=\"myth-you-need-regular-calcitonin-testing-while-on-ozempic\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Myth: &#8220;You Need Regular Calcitonin Testing While on Ozempic&#8221;<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Reality:<\/strong> Routine calcitonin monitoring is not recommended for patients without specific risk factors. Such screening can lead to false positive results and unnecessary anxiety or interventions. Healthcare providers monitor based on individual circumstances rather than blanket screening protocols.<\/p>\n<h2 id=\"practical-takeaways-for-patients\" class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">Practical Takeaways for Patients<\/h2>\n<h3 id=\"understanding-your-individual-risk\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Understanding Your Individual Risk<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">For most individuals considering Ozempic, thyroid cancer risk appears theoretical rather than demonstrated:<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>General population:<\/strong> No confirmed increased risk based on current human evidence from clinical trials and real-world use.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>High-risk individuals:<\/strong> Personal or family history of MTC or MEN 2 represents a clear contraindication requiring alternative treatments.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Everyone else:<\/strong> Falls between these extremes, while with current evidence suggesting very low to negligible risk, though long-term monitoring continues.<\/p>\n<h3 id=\"making-informed-decisions\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Making Informed Decisions<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Consider the full picture:<\/strong><\/p>\n<ul class=\"[li_&amp;]:mb-0 [li_&amp;]:mt-1 [li_&amp;]:gap-1 [&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\">\n<li class=\"whitespace-normal break-words pl-2\">Benefits of treatment for diabetes management or weight loss<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Your individual risk factors and medical history<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Alternative treatment options available<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Current evidence regarding thyroid safety<\/li>\n<\/ul>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Discuss with providers:<\/strong><\/p>\n<ul class=\"[li_&amp;]:mb-0 [li_&amp;]:mt-1 [li_&amp;]:gap-1 [&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\">\n<li class=\"whitespace-normal break-words pl-2\">Your specific medical and family history<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Any concerns about Ozempic cancer risk<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Appropriate monitoring based on your circumstances<\/li>\n<li class=\"whitespace-normal break-words pl-2\">Alternative treatments if you have contraindications<\/li>\n<\/ul>\n<h3 id=\"moving-forward-confidently\" class=\"text-text-100 mt-2 -mb-1 text-base font-bold\">Moving Forward Confidently<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Understanding that current evidence doesn&#8217;t support widespread thyroid cancer concerns for most users helps inform decisions without unnecessary fear. The boxed warning reflects appropriate regulatory caution protecting specific high-risk individuals rather than indicating general population danger.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Ongoing research and surveillance continue monitoring semaglutide thyroid cancer risk, providing increasingly robust data about long-term safety. Current evidence supports use in appropriate patients without contraindications under medical supervision.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">At Heally, our healthcare providers conduct thorough medical history reviews before prescribing GLP-1 medications, screen for contraindications including thyroid cancer risk factors, provide clear education about warnings and what they mean, and offer ongoing monitoring and support throughout treatment.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Ready to discuss whether GLP-1 medications are appropriate for you with healthcare providers who understand both benefits and risks? <a href=\"https:\/\/md.getheally.com\/f\/vshop-book_appt?visit_type_first=true&amp;utm_source=blog\">Schedule a consultation with Heally today.<\/a><\/p>\n<p>&nbsp;<\/p>\n<h3 id=\"sources\">Sources<\/h3>\n<p>NIH: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37531876\/\">Semaglutide and cancer: A systematic review and meta-analysis<\/a><\/p>\n<p>NIH: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20203154\/\">Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation<\/a><\/p>\n<p class=\"whitespace-pre-wrap break-words\">ScienceDirect: <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0753332224015543\"><span class=\"title-text\">Semaglutide decelerates the growth and progression of breast cancer by enhancing the acquired antitumor immunity<\/span><\/a><\/p>\n<p>Clayman Thyroid Center: <a href=\"https:\/\/www.thyroidcancer.com\/blog\/do-glp-1-weight-loss-shots-like-ozempic-and-mounjaro-really-raise-thyroid-cancer-risk#:~:text=The%20FDA%20warning%20specifically%20addresses,rodent%20studies%2C%20not%20human%20data.\">Do GLP-1 Weight-Loss Shots Like Ozempic and Mounjaro Really Raise Thyroid Cancer Risk?<\/a><\/p>\n<div id=\"banner\" class=\"Banner\">\n<div class=\"wrapper truncated\">\n<div aria-live=\"polite\">\n<p>Jama: <a href=\"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2820833\">Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes<\/a><\/p>\n<p>The New England Journal of Medicine: <a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1607141\">Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes<\/a><\/p>\n<p>NIH: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10490004\/\">Novel Treatments for Obesity: Implications for Cancer Prevention and Treatment<\/a><\/p>\n<p>NIH: <a href=\"https:\/\/clinicaltrials.gov\/study\/NCT02607865\">Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes (PIONEER 3)<\/a><\/p>\n<\/div>\n<div aria-live=\"polite\">\n<p>AJMC: <a href=\"https:\/\/www.ajmc.com\/view\/glp-1-agonists-may-reduce-cancer-risk-for-patients-with-diabetes\">GLP-1 Agonists May Reduce Cancer Risk for Patients With Diabetes<\/a><\/p>\n<p>NIH: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12303005\/\">The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n<p>&nbsp;<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Educational Disclaimer: This content is for informational purposes only and is not intended to provide medical advice, diagnosis, or treatment recommendations. Individual experiences may vary significantly. Always consult with a qualified healthcare provider before making decisions about any medication or treatment approach.<\/strong><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"Understanding the relationship between Ozempic thyroid cancer concerns and actual scientific evidence helps individuals make informed decisions about&hellip;\n","protected":false},"author":7,"featured_media":36938,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[467,1799,1795,1794],"tags":[1921,1797,1793,1796,1801,1765],"class_list":{"0":"post-36932","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-cancer","8":"category-ozempic","9":"category-semaglutide","10":"category-weight-loss","11":"tag-libido","12":"tag-ozempic","13":"tag-semaglutide","14":"tag-semaglutide-injections","15":"tag-wegovy","16":"tag-weight-loss"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ozempic Thyroid Cancer: What the Research Actually Says<\/title>\n<meta name=\"description\" content=\"Learn what research says about Ozempic and thyroid cancer. Understand the evidence, FDA warnings, who&#039;s at risk, and separate fact from fear.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ozempic Thyroid Cancer: What the Research Actually Says\" \/>\n<meta property=\"og:description\" content=\"Learn what research says about Ozempic and thyroid cancer. Understand the evidence, FDA warnings, who&#039;s at risk, and separate fact from fear.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research\" \/>\n<meta property=\"og:site_name\" content=\"Heally\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/getheally.com\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-25T16:13:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-26T15:41:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2026\/02\/ozempic_thyroid_cancer.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Heally\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Heally\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"10 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research#article\",\"isPartOf\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research\"},\"author\":{\"name\":\"Heally\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/af10deadfddea19cb3f5e0f3919632ea\"},\"headline\":\"Ozempic Thyroid Cancer: What the Research Actually Says\",\"datePublished\":\"2026-02-25T16:13:10+00:00\",\"dateModified\":\"2026-02-26T15:41:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research\"},\"wordCount\":2068,\"publisher\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research#primaryimage\"},\"thumbnailUrl\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2026\/02\/ozempic_thyroid_cancer.jpg\",\"keywords\":[\"libido\",\"Ozempic\",\"semaglutide\",\"Semaglutide injections\",\"wegovy\",\"weight loss\"],\"articleSection\":[\"Cancer\",\"Ozempic\",\"Semaglutide\",\"Weight Loss\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research\",\"url\":\"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research\",\"name\":\"Ozempic Thyroid Cancer: What the Research Actually Says\",\"isPartOf\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research#primaryimage\"},\"image\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research#primaryimage\"},\"thumbnailUrl\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2026\/02\/ozempic_thyroid_cancer.jpg\",\"datePublished\":\"2026-02-25T16:13:10+00:00\",\"dateModified\":\"2026-02-26T15:41:43+00:00\",\"description\":\"Learn what research says about Ozempic and thyroid cancer. Understand the evidence, FDA warnings, who's at risk, and separate fact from fear.\",\"breadcrumb\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research#primaryimage\",\"url\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2026\/02\/ozempic_thyroid_cancer.jpg\",\"contentUrl\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2026\/02\/ozempic_thyroid_cancer.jpg\",\"width\":1000,\"height\":667,\"caption\":\"Woman feeling her neck. Worried about thyroid cancer\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/getheally.com\/patients\/news\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ozempic Thyroid Cancer: What the Research Actually Says\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#website\",\"url\":\"https:\/\/getheally.com\/patients\/news\/\",\"name\":\"Heally\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/getheally.com\/patients\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#organization\",\"name\":\"Heally\",\"url\":\"https:\/\/getheally.com\/patients\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/wpcdn.getheally.com\/patients\/wp-content\/uploads\/2019\/05\/12231047\/heallybl.png\",\"contentUrl\":\"https:\/\/wpcdn.getheally.com\/patients\/wp-content\/uploads\/2019\/05\/12231047\/heallybl.png\",\"width\":152,\"height\":52,\"caption\":\"Heally\"},\"image\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/getheally.com\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/af10deadfddea19cb3f5e0f3919632ea\",\"name\":\"Heally\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ozempic Thyroid Cancer: What the Research Actually Says","description":"Learn what research says about Ozempic and thyroid cancer. Understand the evidence, FDA warnings, who's at risk, and separate fact from fear.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research","og_locale":"en_US","og_type":"article","og_title":"Ozempic Thyroid Cancer: What the Research Actually Says","og_description":"Learn what research says about Ozempic and thyroid cancer. Understand the evidence, FDA warnings, who's at risk, and separate fact from fear.","og_url":"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research","og_site_name":"Heally","article_publisher":"https:\/\/getheally.com","article_published_time":"2026-02-25T16:13:10+00:00","article_modified_time":"2026-02-26T15:41:43+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2026\/02\/ozempic_thyroid_cancer.jpg","type":"image\/jpeg"}],"author":"Heally","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Heally","Est. reading time":"10 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research#article","isPartOf":{"@id":"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research"},"author":{"name":"Heally","@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/af10deadfddea19cb3f5e0f3919632ea"},"headline":"Ozempic Thyroid Cancer: What the Research Actually Says","datePublished":"2026-02-25T16:13:10+00:00","dateModified":"2026-02-26T15:41:43+00:00","mainEntityOfPage":{"@id":"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research"},"wordCount":2068,"publisher":{"@id":"https:\/\/getheally.com\/patients\/news\/#organization"},"image":{"@id":"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research#primaryimage"},"thumbnailUrl":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2026\/02\/ozempic_thyroid_cancer.jpg","keywords":["libido","Ozempic","semaglutide","Semaglutide injections","wegovy","weight loss"],"articleSection":["Cancer","Ozempic","Semaglutide","Weight Loss"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research","url":"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research","name":"Ozempic Thyroid Cancer: What the Research Actually Says","isPartOf":{"@id":"https:\/\/getheally.com\/patients\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research#primaryimage"},"image":{"@id":"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research#primaryimage"},"thumbnailUrl":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2026\/02\/ozempic_thyroid_cancer.jpg","datePublished":"2026-02-25T16:13:10+00:00","dateModified":"2026-02-26T15:41:43+00:00","description":"Learn what research says about Ozempic and thyroid cancer. Understand the evidence, FDA warnings, who's at risk, and separate fact from fear.","breadcrumb":{"@id":"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research#primaryimage","url":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2026\/02\/ozempic_thyroid_cancer.jpg","contentUrl":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2026\/02\/ozempic_thyroid_cancer.jpg","width":1000,"height":667,"caption":"Woman feeling her neck. Worried about thyroid cancer"},{"@type":"BreadcrumbList","@id":"https:\/\/getheally.com\/patients\/news\/ozempic-thyroid-cancer-research#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/getheally.com\/patients\/news"},{"@type":"ListItem","position":2,"name":"Ozempic Thyroid Cancer: What the Research Actually Says"}]},{"@type":"WebSite","@id":"https:\/\/getheally.com\/patients\/news\/#website","url":"https:\/\/getheally.com\/patients\/news\/","name":"Heally","description":"","publisher":{"@id":"https:\/\/getheally.com\/patients\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/getheally.com\/patients\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/getheally.com\/patients\/news\/#organization","name":"Heally","url":"https:\/\/getheally.com\/patients\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/","url":"https:\/\/wpcdn.getheally.com\/patients\/wp-content\/uploads\/2019\/05\/12231047\/heallybl.png","contentUrl":"https:\/\/wpcdn.getheally.com\/patients\/wp-content\/uploads\/2019\/05\/12231047\/heallybl.png","width":152,"height":52,"caption":"Heally"},"image":{"@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/getheally.com"]},{"@type":"Person","@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/af10deadfddea19cb3f5e0f3919632ea","name":"Heally"}]}},"_links":{"self":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts\/36932","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/comments?post=36932"}],"version-history":[{"count":12,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts\/36932\/revisions"}],"predecessor-version":[{"id":36945,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts\/36932\/revisions\/36945"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/media\/36938"}],"wp:attachment":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/media?parent=36932"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/categories?post=36932"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/tags?post=36932"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}